The role of primary care physicians in cognitive screening for early stage Alzheimer's

New early stage Alzheimer’s disease treatments — such as Lecanemabwhich was recently given accelerated approval from the FDA — are preparing to be launched into the market place. As a result, patients will want to learn more about the importance of cognitive screening and their treatment options.

Medical Economics sat down with John Showalter, M.D., of Linus Health, to discuss the role for primary care physicians in screening for cognitive issues such as Alzheimer’s and dementia.